In this episode of RARE on the Run, rare disease community experts comment on the newly released guidelines from the U.S. Food and Drug Administration on clinical research during the novel coronavirus and COVID-19 outbreak.

Hear about what these guidelines mean for patients and the future of clinical research for the rare disease community from Terry Jo Bichell, PhD, MPH, director at COMBINEDBrain, Andra Stratton, co-founder and president at Lipodystrophy United, and Jason Sicklick, MD, FACS, surgical oncologist at UC San Diego Health. For more information on this topic, please visit the COVID-19 resource page.